Device-associated infection rates, mortality, length of stay and bacterial resistance in intensive care units in Ecuador: International Nosocomial Infection Control Consortium’s findings

Table 1 Pooled means of the distribution of crude mortality, crude excess mortality, length of stay, and crude excess length of stay, of adult intensive care unit patients with and without device-associated healthcare-acquired infection

Patients	Patients, n	Deaths, n	Pooled crude mortality, %	Pooled crude excess mortality, % (95%CI)	LOS, total days	Pooled average, LOS (d)	Pooled average, excess LOS (d) (95%CI)
Without DA-HAI	678	107	15.80	-	3579	5.3
With CLABSI	15	7	46.70	30.9 (8.1-54.7)	190	12.7	7.4 (5.8-9.2)
With CAUTI	12	4	33.30	17.6 (-3.2-46.4)	174	14.5	9.2 (7.3-11.4)
With VAP	43	13	30.20	14.5 (4.1-27.4)	434	10.1	4.8 (4.1-5.7)

DA-HAI: Device-associated healthcare-acquired infection; CLABSI: Central line-associated bloodstream infection; VAP: Ventilator-associated pneumonia; CAUTI: Catheter-associated urinary tract infection; LOS: Length of stay.